NG
SLXP

NatWest Group’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

NatWest Group’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1,940
Closed -$201K – 630
2014
Q1 		$201K Buy
+1,940
New +$201K 0.01% 532
2013
Q4 		– Sell
-8,654
Closed -$579K – 994
2013
Q3 		$579K Buy
+8,654
New +$579K 0.02% 647